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Sixty-five members of three families with limb girdle muscular dystrophy (LGMD) underwent neurological, cardiological, 
and ancillary investigations. Thirty-five individuals were diagnosed as having slowly progressive autosomal dominant 
LGMD. Symmetrical weakness started in the proximal lower limb muscles, and gradually upper limb muscles also 
became dected. Early contractures of the spine were absent. Contractures of elbows and Achilles tendons were either 
minimal or late. Serum creatine kinase activity was normal to moderately elevated. Electromyogram and muscle biopsy 
were consistent with a mild muscular dystrophy. Cardiological abnormalities, found in more than one-half the patients, 
included dysrhythmias and atrioventricular (AV) conduction disturbances presenting as bradycardia, syncopal attacks 
necessitating pacemaker implantation, and sudden cardiac death. There was a significant relation between the severity 
of AV conduction disturbances and age. In nearly all patients, neuromuscular symptomatology preceded cardiological 
involvement. The early recognition of this previously not described, autosomal dominant LGMD with life-threatening 
cardiac involvement offers an opportunity for therapeutic intervention. 
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Cardiac involvement is well documented in  various 
forms of muscular dystrophy, such as Duchenne,  
Becker, Emery-Dreifuss, and  myotonic dystrophy. Its 
prevalence, severity, and  distinctive characteristics vary 
from one type of dystrophy to another [1-91. Limb 
girdle muscular dystrophy (LGMD) (constitutes a het- 
erogeneous group of disorders with a limb girdle distri- 
bution of weakness. Dur ing  a recent workshop, criteria 
for inclusion and  exclusion of the diagnosis have been 
suggested [ 101. Although cardiological involvenient has 
been described in  LGMD [l, 3, 6 ,  1 1-13], in  more  
recent reports, clinically overt cardiac abnormalities ap- 
pear to  be rare [4, 14, 151. 
In this report, we describe three families with a unique 
neuromuscular disease of myopathic origin, characterized 
by autosomal dominant inheritance, slowly progressive limb 
girdle weakness, the absence of early contractures, and cardi- 
opathy with life-threatening arrhythmias. 
Subjects and Methods 
Subjects 
Sixty-five members ofthree families (27 individuals from family 
A, 35 from family B, and 3 from family C), ofwhich one origi- 
nated from The Netherlands (A), one from Surinam (B), and 
one from the Caribbean (C), underwent neurological, cardio- 
logical, and biological investigations after having given their 
informed consent. Pedigrees are shown in Figure 1. Asymptom- 
atic persons under the age of 18 were excluded from the study. 
In 1 1 deceased subjects (4 in family A, 6 in family B, and 1 in 
family C) and 9 subjects living abroad (7 in family B, 2 in family 
C), the history was given by the family. 
Neurological Investigations 
The patients and family members were examined by using 
a btandardized protocol to determine age and symptoms at 
onset, disease duration, and clinical features, including pul- 
monary function tests. Some were investigated at home, but 
the majority was examined in our hospital. 
The three index cases (AII-9, BIII-8, CII-6) met the diag- 
nostic criteria for limb girdle dystrophy [lo], i.e., slowly pro- 
gressive symmetrical proximal weakness with onset in the 
lower limbs, gradual involvement of the upper limbs, normal 
to mildly raised serum creatine kinase (CK) activity, myo- 
pathic changes on electromyography (EMG) and muscle 
biopsy, and normal dystrophin analysis of the muscle tis- 
sue. 
For other individuals within these families, the presence 
of proximal weakness in at least the lower limbs, or CK 
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Fig I .  Pedigrees offamilies A, B, and C. 
elevation (greater than two times the normal value) was re- 
quired for inclusion in the affected group. 
Cardio logical Investigations 
This included history, physical examination, 12-lead scalar 
electrocardiogram (ECG), two-dimensional and M-mode 
echocardiography, and color flow Doppler in 5 1 subjects (23 
of family A, 27 of family B, 1 of family C). In  29 persons, 
24-hour ECG monitoring, and in 3, cardiac muscle biopsy, 
were performed. From 16 other subjects, including some of 
the deceased, cardiologic information was obtained from 
their cardiologists. Abnormalities were classified as arrhyth- 
mias, either bradycardias or tachycardias, and echocardio- 
graphic wall-motion abnormalities indicating a myocardial 
muscle disease. Other findings such as coronary artery disease 
were classified as miscellaneous. 
Biological Investigations 
In 65 members of the three families, serum CK activity was 
assessed. EMG, including nerve-conduction studies, was per- 
formed in 5 members of family A and 2 individuals of family 
B. Biopsy specimens of the biceps brachii or quadriceps mus- 
cle were obtained from 10 subjects (3 of family A, 4 of family 
B, and 3 of family C )  for histopathological and histochemical 
studies. 
Postmortem examination was performed in 2 individuals 
(MI-6, BIII-6) who had died suddenly. 
x 2  tests were conducted to analyze the relationship be- 
tween the severity of atrioventricular (AV) conduction distur- 
bances and age. 
Results 
Neurological Evaluation 
Among the 65 examined subjects, 35 (14 in family A, 
18 in family B, and 3 in family C; 15 females, 20 
males, ranging in age from 15 to 66 years) were diag- 
nosed as having LGMD. Thirty-four individuals had 
neuromuscular symptoms, and one 27-year-old male 
was clinically asymptomatic but had an elevated serum 
CK activity (25 times the normal value). Eleven de- 
ceased subjects and 9 individuals living abroad were 
presumed to be affected according to the history given 
by the family. 
The pattern of inheritance of the muscle disorder in 
families A and B is autosomal dominant. Affected per- 
sons were found in at least three generations, males 
and females were equally affected, and male-to-male 
transmission was present. In family C, transmission is 
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Table 1. Clinical Data and Results of Ancillary Investigations in Three Families with Autosomal 
Dominant Limb Girdle Muscular DystropIly 
No. of No. of 
Individuals Age Individuals Age of Weakness CK (X  Normal Muscle 
Family Examined (yr) Affected Onset (yr) at Onset Progression Value) EMG Biopsy 
A 27 20-66 14 5-38 PLL Mild N-4 M M 
B 35 15-65 18 4-29 PLL Mild N-25 M M 
C 3 36-39 3 4-19 PLL Mild 6-13 M M 
CK = crearine kmase; EMG = electromyogram; N = normal; M = myopathic; PLL = proximal lower limbs. 
suggestive of autosomal dominant inheritance, because 
of the presence of affected persons in two generations. 
The neurological data and results of ancillary investiga- 
tions are presented in Table 1. All patients had normal 
motor milestones. Age of onset varied from 4 to 38 years. 
In one-half the patients the onset was in childhood with 
a typical waddling gait, an abnormal posture with hyper- 
lordosis, or difficulty with running. Subsequently, there 
was difficulty in climbing stairs and in arising from a 
squatting position. Muscle weakness was slowly progres- 
sive, causing moderate impairment in the sixth or seventh 
decade. The first abnormalities found on examination 
were an increased lumbar lordosis, a positive Gowers’ 
sign, and hip girdle or proximal leg weakness. Mild 
symmetrical weakness and wasting of proximal arm mus- 
cles, affecting predominantly the biceps brachii muscle, 
occurred around the age of 40. Restriction of neck or 
spine flexion was absent. Flexion contractures of elbows 
and Achilles tendons were either minimal or late, al- 
though 2 individuals (AIII-26, BIII-32) underwent 
Achilles tenotomy in their teens. Mild symmetrical facial 
involvement was seen in 3 individuals. Some distal leg 
involvement was observed in 8 individuals, but proximal 
weakness was always more severe. Calf hypertrophy was 
seen in 6 individuals. Sensation was not impaired. Deep 
tendon reflexes were reduced or absent. Myotonia was 
not present. Pulmonary function was either normal or 
slightly reduced. 
Serum CK activity was normal in 7 and elevated 
(median, three times the normal value) in 28 affected 
individuals. 
Motor and sensory nerve conduction velocities were 
normal in all patients investigated. Needle examination 
showed polyphasic short-duration, low-amplitude mo- 
tor unit action potentials, with fast recruitment in pre- 
dominantly the proximal muscles, but to a lesser extent 
also in distal muscles. 
Muscle biospy showed predominantly nonspecific 
myopathic changes in both fiber types, such as fiber 
size variation, increase in the number of fibers with 
internal nuclei, fiber splitting, and slight endomysial 
fibrosis and fatty infiltration (Fig 2). In seven biopsies 
(AII-6, 9, AIII-29, BIII-6, CII-5, 6, 7) an occasional 
Fig 2. Biopsy specimen fiom the biceps brachii muscle show- 
ing rnyopathic changes, including muscle-fiber size variation, 
an increase in the number offibers with internal nuclei, and 
fiber splitting (hematoxylin and eosin stain) (X 50 before 
36% reduction). 
necrotic fiber with phagocytosis or regenerating fiber 
was seen. Other structural changes included moth- 
eaten fibers (AII-9) and rimmed vacuoles (3%) (BIII-8). 
Electron microscopy in the latter showed filamentous 
inclusions. A few atrophic angulated fibers were found 
in nearly all muscle biopsy specimens, but in only two 
specimens these fibers reacted stongly with oxidative 
enzymes. Immunohistochemical and immunobiochemi- 
cal dystrophin analysis in the muscle biopsy specimens 
of the 3 index cases was normal. 
Postmortem examination of the spinal cord of 
AII-6 showed normal motor neurons. 
Cardiological Evaluation 
Information about cardiological investigations was 
available in 67 subjects (51 personally examined; for 
16 individuals data from their own cardiologists were 
obtained). Sudden cardiac death, witnessed by relatives, 
occurred in 8 patients (AII-3, 6, 8, BI-1, BII-5, 
BIII-6, 16, CI-1) at a relatively young age (median, 50 
years; range, 42-76 years). In Table 2, the characteristics 
of AV conduction in 40 individuals with neuromuscular 
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Table 2. Characteristics of Atrioventricular Conduction in 40 Individuals with Neuromuscular Symptomsa 
Age (yd 15-25 25-35 35-45 45-55 55-65 
Normal 5 10 - - - 
- - 4 1 First-degree AV block - 
Second-degree AV block 1 2 
High-degree and total AV block 
Pacemaker implantation 1 2 7 
- - - 
- 4 1 2 - 
- - 
‘Thirty five patients were clinically examined; from an additional 5 patients, cardiological information was available 
AV = atrioventricular. 
symptoms are shown. Five subjects showed first-degree 
AV block. In 3 individuals, second-degree AV block was 
present, 2 showing Wenckebach type and 1 a 2: 1 AV 
conduction. In 6 individuals, atrial fibrillation with slow 
ventricular response rates (frequency, 28-50/min) was 
found. In the absence of medication influencing AV 
conduction, this is indicative of intrinsic AV block. AIII- 
16 also had a total AV block with slow ventricular 
response rates. A pacemaker had been implanted in 10 
individuals (AII-5, 6, 8, 10, BII-1, 3, 7, BIII-17, 30, 
(211-6) because of symptomatic high-degree or total AV 
block (Fig 3). Fourteen of the 51 examined patients 
complained of palpitations. One patient had paroxysmal 
atrial fibrillation with fast ventricle response. Frequent 
supraventricular premature beats were recorded in 11 
individuals on Holter electrocardiography. Short ven- 
tricular tachycardias, runs from 2 to 6 beats, were seen 
in 11 patients. In another 4 patients (BII-7, BIII-8, 17, 
23), signs of sick sinus syndrome were found, such as 
sinus bradycardia and sinus arrest. 
Dilated cardiomyopathy was documented with echo- 
cardiography in 2 patients (AIII-7, BIII-16). AIII-7 pre- 
sented at the age of 39 with acute heart failure. BIII-I6 
presented at the age of 46 with fatigue and nausea that 
had been present for aweek. He had atrial fibrillation with 
slow response rates and a dilated cardiomyopathy. He 
died suddenly at the age of 47. Postmortem examination 
was not executed. Echocardiography showed wall-motion 
disturbances of the intraventricular septum in 2 individu- 
als (AII-9, BIII-23), of whom 1 had a left bundle branch 
block. Left atrial enlargement was observed in 6 patients 
(AII-9, BII-7, BIII-6,16,17, CII-7), all with atrial rhythm 
disturbances. 
Patient AII-6 died suddenly at the age of 63 years. 
He was known to have had heart disease and had had 
a pacemaker implanted. The postmortem examination 
revealed cardiomegaly with dilation of all cardiac 
chambers. The left ventricular myocardium showed ex- 
tensive replacement fibrosis, which extended also into 
the ventricular septum. The septa1 AV junction area 
was markedly attenuated as part of the chamber dila- 
tion. The AV node was in its normal position. At the 
site of the anticipated penetrating (His) bundle, how- 
ever, the larger part of the specialized conduction cells 
was replaced by fibrous tissue. The crest of the ventric- 
ular septum, moreover, contained extensive replace- 
ment fibrosis. The pathologic findings suggest an ac- 
quired degenerative process related to molding of the 
central fibrous body as a consequence of massive dila- 
tion of heart chambers. 
Another patient, BIII-6, died suddenly at the age of 
47, and he was known to have atrial fibrillation with 
slow response rates and ventricular premature beats. 
Postmortem investigation and cardiac angiography 
HEWLETT-PACKARD REORDER40444A 4 0 4 4 4 8  
Fig 3. Rhythm strip of AII-10, aJter electroconversion from atrial jibrillation to sinus rhythm, showing total atrioventricuhr block 
with junctional escape rhythm, and a ventricular extraystole (paper speed = 25 mm/sec). 
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showed a hypertrophic heart with a moderate stenosis 
of the right coronary artery. No ischemic changes 
could be demonstrated in the cardiac muscle cells. The 
conduction system was not analyzed. 
Cardiac muscle biopsy in 3 cases (AIII-7, BIII-16, 
CII-7) showed nonspecific fibrotic changes. 
A history of ischemic heart disease was given by 8 
of the 40 LGMD patients (AII-5, 6, 7, 8, 9, BIII-17, 
23, 32), and by 2 of the unaffected family members 
(AII-11, BIII-19) in whom cardiological information 
was available. Three (AII- 5, 6, 1 1) underwent coronary 
artery bypass grafting, and the other '7 had myocardial 
infarction. One of them (BIII-32) had severe pump 
failure on the basis of ischemic heart disease and was 
presented for cardiac transplantation. 
One patient (BIII-37) suffered from systemic lupus 
erythematosus (SLE) and showed pericarditis. 
Relation Between Cardiological and 
Neurological Observations 
Cardiological abnormalities were found in 2 1 of the 35 
examined patients with LGMD (and in an additional 4 
of the 5 patients with LGMD in whom cardiological 
information was available) (see Fig 1, Table 2) and 
consisted of conduction disorders, presenting as first-, 
second-, or third-degree AV block, and atrial fibrilla- 
tion with high-degree AV block. Myocardial muscle 
disease resulting in congestive cardiomyopathy was 
found in 2 individuals. No medical records document- 
ing sudden cardiac death were available. Possible causes 
may be either severe bradyarrhythmias or tachyarrhyth- 
mias, such as ventricular tachycardia or fibrillation, or 
coronary artery disease. 
With the exception of 2 patients, the AV conduction 
disturbances were never present without and always 
preceded by neuromuscular symptoms. The cardiac 
symptoms could be the most prominent. One patient 
(BIII-16) even died of cardiac disease, without LGMD 
having been diagnosed. In retrospect, he was said to 
have had the neuromuscular symptoms characteristic 
of the disorder. Another 27-year-old individual (BIV- 
37) showed alternating first- and second-degree AV 
block on his ECG but no muscle weakness. Calf hyper- 
trophy and a markedly raised serum CK activity (up to 
25 times the normal value) indicated (presymptomatic) 
neuromuscular disease. x2 testing showed a significant 
relation between the severity of AV conduction distur- 
bances and age ( p  < 0.001). 
Discussion 
We identified 35 individuals within three families with 
an autosomal dominantly inherited progressive limb 
girdle muscular weakness. The presenting symptoms 
were due to hip girdle or proximal leg weakness and 
occurred predominantly in the first two decades. 
Weakness of the shoulder girdle, upper arm muscles, 
and distal leg muscles occurred at a later stage of the 
disease, and slight symmetrical facial weakness was seen 
in only 3 patients. Eleven patients showed either mini- 
mal or late contractures of elbows and Achilles ten- 
dons. Progression of the neuromuscular disease was 
mild, since no patient became wheelchair dependent. 
There was marked inter- and intrafamilial variability. 
Serum CK activity was normal to mildly elevated in 
most of the patients. O n  the basis of electrophysiologi- 
cal and histopathological investigations, it can be con- 
cluded that we are dealing with a mild muscular dys- 
trophy. All these features found in our families can fit 
in a general description of autosomal dominant 
LGMD, but the cardiological involvement, present in 
more than one-half our patients, is exceptional. 
Recently, two forms of LGMD with autosomal 
dominant inheritance were distinguished [ 16, 171. One 
form, called Bethlem myopathy [18], has an early, of- 
ten congenital onset and is characterized by proximal 
or generalized muscle weakness, joint contractures, and 
absence of cardiac signs and symptoms [5]. The other 
form constitutes a heterogeneous group of disorders 
with later onset and a slowly progressive course [19- 
281. No cardiac involvement was noted, except for the 
family described by De Coster and associates [21], who 
found mild repolarization disturbances on ECG in 1 
individual. The main cardiologic manifestations in our 
families comprised conduction disturbances in the 
atrial region, AV node, and bundle of His, presenting 
as AV block, atrial fibrillation with high-degree AV 
block and junctional escape rhythm, bradycardia espe- 
cially during the night, and syncopal attacks. The 1 
patient in whom the cardiac AV conduction system 
could be studied showed extensive degenerative disease 
that involved the His bundle at the site of penetration 
into the central fibrous body. The area was markedly 
attenuated, which correlated with distinct dilation of 
the cardiac chambers. These changes, moreover, also 
tended to affect the AV conduction. This could pro- 
vide the anatomic substrate for AV nodal dissociation 
and total AV block. In addition, it may anticipate from 
these findings that with increasing age, the AV con- 
duction disturbances will become more severe. Indeed, 
the statistically significant higher frequency of severe 
cardiological disturbances in the older age groups en- 
dorses this conclusion. T o  what extent replacement fi- 
brosis of myocardium as part of ischemic heart disease 
plays an additional role remains speculative. Since isch- 
emic heart disease was found both in individuals with 
and without LGMD, it is not believed to be the under- 
lying cause of the conduction disturbances that were 
found in concomitant presence with the neuromuscular 
disease. Since the latter is the case, cardiological screen- 
ing by ECG and 24-h ECG of family members pre- 
senting with neuromuscular signs and symptoms is 
recommended. Follow-up is mandatory when abnor- 
malities are found, and implantation of a pacemaker 
to prevent sudden cardiac death should be considered 
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when extreme bradycardias and related symptoms are 
present. Fortuitous ventricular arrhythmias, however, 
are more difficult to be influenced. 
In only 2 patients a congestive cardiomyopathy was 
encountered. Thus, in our families it seems unlikely that 
the conduction disturbances and cardiomyopathy are to 
be considered mutually dependent as suggested by some 
authors [29]. The presence of congestive heart failure 
seems an additional risk factor for sudden death. Life- 
threatening conduction disturbances are described in 
only a few neuromuscular disorders, including myotonic 
dystrophy and a genetically heterogeneous variant [4, 
30, 311, a multisystem disorder, and Emery-Dreifuss 
muscular dystrophy (EDMD) [7,8]. The latter is charac- 
terized by early contractures of the Achilles tendons, 
elbows, and postcervical muscles, slowly progressive 
wasting and weakness with a predominantly humeroper- 
oneal distribution, and cardiomyopathy with conduc- 
tion defects [7, 8, 321. Predominantly myopathic 
changes on EMG and muscle biopsy have been de- 
scribed, although some authors [33,34] also found neu- 
rogenic changes. Most families show X-linked recessive 
inheritance. The gene responsible for EDMD was re- 
cently identified in the relomeric moiety of Xq28. Vari- 
ous mutations were found in the STA gene causing lack 
of the protein emerin [35-381. There have been several 
reports of families with (possible) autosomal dominant 
scapulo-humero-peroneal weakness with cardiopathy 
[39-511, which according to Emery [52] should be 
considered EDMD. As yet, the gene(s) responsible for 
this phenotypically identical disease is not identified. 
In contrast to EDMD, the affected individuals in our 
families presented with slowly progressive pelvic girdle 
weakness with only late involvement of the humeral mus- 
cles and sparing of the peroneal and tibia1 muscles. In 6 
of our patients, calf enlargement was seen, which has 
been an exclusion criterion for EDMD [32]. Early con- 
tractures of neck, spine, elbows, and Achilles tendons, 
being a salient feature of EDMD, were absent in our 
patients. In nearly all the affected individuals of our 
families, neuromuscular symptoms precede the cardio- 
logical disturbances, whereas in EDMD cardiological 
involvement may occur at any age or may even be present 
at the very onset [7, 8, 321. 
There are a few anecdotal reports of families with 
evidence of possible autosomal dominantly or reces- 
sively inherited humeropelvic weakness and cardiac 
involvement [53-551. Because of contractures oc- 
curring in childhood, these families are also regarded 
as having EDMD [52].  
The neurological manifestations in the family de- 
scribed by Graham [56] resemble those encountered 
in our families in some respects, but the cardiological 
manifestations consisting of predominant left ventricle 
hypertrophy are clearly different. 
hmmed  vacuoles and filamentous inclusions were 
encountered in only one of the 10 biopsy specimens 
of our patients. Therefore, a diagnosis of familial inclu- 
sion body myositis, or autosomal dominant LGMD 
with rimmed vacuoles, as described by Chutkow and 
colleagues [20], is considered unlikely. Probably, we 
are dealing with a nonspecific feature [57]. 
Therefore, we conclude that the patients in our fam- 
ilies are suffering from a new, hitherto not described, 
disease entity in which cardiac involvement predomi- 
nates the clinical picture. Timely recognition of this 
disorder may offer an opportunity for therapeutic car- 
diological intervention. 
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